+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stomach Cancer Treatment Market by Treatment Type, Route of Administration, Distribution Channel, Stage, End User, Histologic Type - Global Forecast to 2030- Product Image
Stomach Cancer Treatment Market by Treatment Type, Route of Administration, Distribution Channel, Stage, End User, Histologic Type - Global Forecast to 2030- Product Image
Sale

Stomach Cancer Treatment Market by Treatment Type, Route of Administration, Distribution Channel, Stage, End User, Histologic Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012198
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The stomach cancer treatment market is undergoing dynamic change, fueled by innovation in therapeutics, evolving clinical strategies, and shifting policy landscapes. Senior decision-makers need actionable market intelligence to navigate opportunity, manage risk, and drive competitive advantage in this highly complex sector.

Market Snapshot: Stomach Cancer Treatment Market

The stomach cancer treatment market grew from USD 5.55 billion in 2024 to USD 6.10 billion in 2025. It is expected to continue growing at a CAGR of 9.63%, reaching USD 9.64 billion by 2030. Rising demand for targeted and immuno-oncology solutions, alongside incremental regulatory policy updates, is shaping investment decisions across regions. Major stakeholders are continually adapting to a changing landscape—characterized by new treatment modalities, tariff adjustments, and regional growth differentials—that directly impacts patient access and provider strategies.

Scope & Segmentation

This comprehensive report covers the core dimensions of the global stomach cancer treatment market, with deep segmentation and actionable insights. The analysis spans key market variables and the latest technological trends. Major focus areas include:

  • Treatment Types: Chemotherapy (fluorouracil-, platinum-, and taxane-based), Immunotherapy (CTLA-4 and PD-1 inhibitors), Radiotherapy (brachytherapy, external beam), Surgery (partial and total gastrectomy), Targeted Therapies (EGFR, HER2, VEGF inhibitors)
  • Routes of Administration: Intravenous, Oral
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Stages: Stage I, II, III, IV
  • End Users: Homecare, Hospitals, Specialty Clinics
  • Histologic Types: Adenocarcinoma, Carcinoid Tumors, GIST, Lymphoma
  • Regions: Americas (including U.S. states such as California, Texas, New York, Florida, and others; plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including U.K., Germany, France, Saudi Arabia, South Africa, and others), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and more)
  • Companies: F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, Sanofi S.A., Pfizer Inc., Amgen Inc.

Key Takeaways for Stomach Cancer Treatment Market

  • Market growth is powered by scientific breakthroughs in molecular diagnostics, paving the way for more precise patient stratification and personalized therapies in gastric oncology.
  • Therapeutic innovation includes integration of immuno-oncology agents and advanced targeted regimens, shifting standards of care toward combination-based protocols and greater survival outcomes.
  • Regional adoption rates vary; robust clinical trial activity and supportive infrastructure accelerate uptake in the Americas, while Asia-Pacific’s fast-expanding healthcare investment drives competition and localized production.
  • Competitive dynamics are evolving, with leading biopharmaceuticals investing in next-generation research platforms and smaller innovators focusing on specialized histologic subtypes and first-in-class mechanisms.
  • Diverse distribution models—from hospital to online and retail pharmacies—are making treatment more accessible, especially as oral therapies increase in use.
  • Histologic subtype differentiation, such as the prevalence of adenocarcinoma and the emergence of GIST and lymphoma cases, is shaping research investment and clinical trial design.

Tariff Impact: US Import Policies and Access to Care

Recent U.S. tariff changes on imported pharmaceuticals have intensified scrutiny of the stomach cancer treatment supply chain. Manufacturers facing increased production costs for chemotherapy agents and biologics are shifting toward domestic manufacturing and forging new supplier alliances. In response, stakeholder strategies now emphasize collaborative procurement and investment in localized facilities to maintain affordability and avoid shortages. Tariff-driven cost increases are also prompting a review of payer negotiations and reimbursement models, as companies balance compliance with market access and patient care requirements.

Methodology & Data Sources

Insights in this report are derived from robust secondary research and targeted primary interviews. Data were triangulated using industry databases, peer-reviewed literature, regulatory filings, and company disclosures. Expert interviews with oncologists, payers, supply chain specialists, and researchers ensured that findings reflect both empirical analysis and real-world perspectives.

Why This Report Matters

  • Enables executives to benchmark portfolio strategy, identify new growth levers, and navigate regulatory uncertainty in gastric oncology.
  • Equips leaders with granular segment and region-specific intelligence to optimize resource allocation and accelerate commercialization plans.

Conclusion

This report provides a thorough, actionable view of the evolving stomach cancer treatment market, guiding senior decision-makers as they plan, invest, and compete in an increasingly sophisticated therapeutic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stomach Cancer Treatment Market, by Treatment Type
8.1. Introduction
8.2. Chemotherapy
8.2.1. Fluorouracil-Based
8.2.2. Platinum-Based
8.2.3. Taxane-Based
8.3. Immunotherapy
8.3.1. Ctla-4 Inhibitors
8.3.2. Pd-1 Inhibitors
8.4. Radiotherapy
8.4.1. Brachytherapy
8.4.2. External Beam
8.5. Surgery
8.5.1. Partial Gastrectomy
8.5.2. Total Gastrectomy
8.6. Targeted Therapy
8.6.1. Egfr Inhibitors
8.6.2. Her2 Inhibitors
8.6.3. Vegf Inhibitors
9. Stomach Cancer Treatment Market, by Route of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
10. Stomach Cancer Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Stomach Cancer Treatment Market, by Stage
11.1. Introduction
11.2. Stage I
11.3. Stage Ii
11.4. Stage Iii
11.5. Stage Iv
12. Stomach Cancer Treatment Market, by End User
12.1. Introduction
12.2. Homecare
12.3. Hospitals
12.4. Specialty Clinics
13. Stomach Cancer Treatment Market, by Histologic Type
13.1. Introduction
13.2. Adenocarcinoma
13.3. Carcinoid Tumors
13.4. Gist
13.5. Lymphoma
14. Americas Stomach Cancer Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Stomach Cancer Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Stomach Cancer Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche AG
17.3.2. Bristol-Myers Squibb Company
17.3.3. Merck Sharp & Dohme Corp.
17.3.4. AstraZeneca PLC
17.3.5. Novartis AG
17.3.6. Takeda Pharmaceutical Company Limited
17.3.7. Daiichi Sankyo Company, Limited
17.3.8. Sanofi S.A.
17.3.9. Pfizer Inc.
17.3.10. Amgen Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STOMACH CANCER TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. STOMACH CANCER TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. STOMACH CANCER TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. STOMACH CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. STOMACH CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STOMACH CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY FLUOROURACIL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PLATINUM-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TAXANE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CTLA-4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PARTIAL GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TOTAL GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HER2 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY VEGF INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CARCINOID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY GIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 74. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 77. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 78. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 79. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 80. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 83. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 87. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 89. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 143. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 144. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 145. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 146. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 147. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 154. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 155. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 156. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 157. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 158. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 176. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 177. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 178. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 179. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 180. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 183. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 187. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 188. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 189. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 190. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 191. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 231. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 232. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 233. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 235. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 251. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 252. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 253. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 254. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 255. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 256. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 257. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 260. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 264. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 265. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 266. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 267. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 268. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 295. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 297. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 298. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 299. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 300. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 301. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 304. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 308. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 309. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 310. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 311. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 312. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 315. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Stomach Cancer Treatment market report include:
  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • AstraZeneca PLC
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Daiichi Sankyo Company, Limited
  • Sanofi S.A.
  • Pfizer Inc.
  • Amgen Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.64 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Stomach Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Disease Indication, By Route Of Administration, By Drug Class, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Stomach Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Disease Indication, By Route Of Administration, By Drug Class, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Gastric Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Image

Gastric Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
HER2-positive Gastric Cancer- Pipeline Insight, 2025 - Product Image

HER2-positive Gastric Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • 550 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.